I’m sure the NEU announcement should bring a bit of love to the sector! Definitely seems like EYE has a bit more going for it with a device (in the high growth MIGS market, CAGR 20%) that is already approved and a potential first ever treatment for a much more common disease
Correct me if I am wrong but…
- $30m market cap ONLY
- Revenue generating ($15m LTM, 28% growth, new product that will drive significantly higher revenue growth for CY23)
- Exciting R&D pipeline —> seeking FDA approval for the first ever treatment for intermediate AMD (affecting 1 in 7 people and the leading cause of blindness)
EYE seems a bit cheap don’t ya reckon
Nova Eye Medical (EYE) Discussion, page-19
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.005(1.82%) |
Mkt cap ! $61.77M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $108.5K | 410.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 157298 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 471179 | 1 |
View Market Depth
| Last trade - 15.46pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
26.5¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 26.5¢ | 27.0¢ | 25.5¢ | 333518 | ||
| Last updated 15.45pm 03/05/2024 ? | |||||
| EYE (ASX) Chart |